WHY ACCELERATE?
of children with cancer resistant to conventional treatment die
of delay until the same new medicine already approved for adults gets approved for children
long-term survivors of childhood cancer live in Europe today. 2/3 of them experience long-term health related problems
HOW TO ACCELERATE
NEWS
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer – An ACCELERATE Multistakeholder Consensus
ASCPT
De Rojas, T. et al.
November 2023